Information for "Artificial Intelligence-Assisted Amphiregulin And Epiregulin IHC Predicts Panitumumab Profit In RAS Wild-Sort Metastatic Colorectal Cancer"
Basic information
| Display title | Artificial Intelligence-Assisted Amphiregulin And Epiregulin IHC Predicts Panitumumab Profit In RAS Wild-Sort Metastatic Colorectal Cancer |
| Default sort key | Artificial Intelligence-Assisted Amphiregulin And Epiregulin IHC Predicts Panitumumab Profit In RAS Wild-Sort Metastatic Colorectal Cancer |
| Page length (in bytes) | 6,573 |
| Page ID | 39220 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | BonnyCarlino466 (talk | contribs) |
| Date of page creation | 15:39, 24 October 2021 |
| Latest editor | BonnyCarlino466 (talk | contribs) |
| Date of latest edit | 15:39, 24 October 2021 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
